WILCO startup cluster December 5, 2018 tokyonne News HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds. Share ThisTweetShareShareEmail Related Posts HEPHAISTOS Laureate of the SANOFI Golden Ticket mRNA 🏆 We are pleased to announce that HEPHAISTOS-Pharma has been awarded a Sanofi’s Golden… “Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket… HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from…
HEPHAISTOS Laureate of the SANOFI Golden Ticket mRNA 🏆 We are pleased to announce that HEPHAISTOS-Pharma has been awarded a Sanofi’s Golden…
“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket…
HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from…